Baupost Group LLC/ma
Seth Klarman, Baupost Group. 10% owner at Orexigen Therapeutics, Inc.; 10% owner at FACET BIOTECH CORP
- Sold, on record
- $13.4M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Oct 31, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Orexigen Therapeutics, Inc.10% owner
- FACET BIOTECH CORP10% owner
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- Orexigen Therapeutics, Inc.2.2M shares
- FACET BIOTECH CORP867,532 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale FACET BIOTECH CORPPlan not statedSep 4, 2009 2009
Sold 867,532 shares at $15.42 ($13.4M)
Baupost Group LLC/ma, 10% owner
Seth KlarmanSold 19.8% of holdings ($67.5M position)3.5M shares leftFirst sale on recordFiling
- 2 Form 4 sale Orexigen Therapeutics, Inc.UnusualOct 25, 2018 +3338 days
Sold 680,500 shares at $0.0100 ($7k)
Baupost Group LLC/ma, 10% owner
Seth KlarmanSold 30.6% of holdings ($22k position)1.5M shares leftFirst sale on recordFiling
- 3 Form 4 sale Orexigen Therapeutics, Inc.UnusualOct 31, 2018 +6 days
Sold 1.5M shares at $0.0100 ($15k)
Baupost Group LLC/ma, 10% owner
Seth KlarmanSold 100% of holdings ($15k position)0 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 31, 2018 | Oct 31, 2018 | Orexigen Therapeutics, Inc. | 10% owner | Form 4 sale | 1.5M | $15k | 100.0% | Unusual | SEC |
| Oct 25, 2018 | Oct 26, 2018 | Orexigen Therapeutics, Inc. | 10% owner | Form 4 sale | 680,500 | $7k | 30.6% | Unusual | SEC |
| Sep 4, 2009 | Sep 8, 2009 | FACET BIOTECH CORP | 10% owner | Form 4 sale | 867,532 | $13.4M | 19.8% | Plan not stated | SEC |